YOUSSEF, M., J. DE SANCTIS, J. SHAH, D. DUMUT, M. HAJDÚCH, A. NAUMOVA, D. RADZIOCH

Treatment of Allergic Asthma With Fenretinide Formulation (LAU-7b) Downregulates ORMDL Sphingolipid Biosynthesis Regulator 3 ( Ormdl3) Expression and Normalizes Ceramide Imbalance. The Journal of Pharmacology and Experimental Therapeutics. 2020, 373(3), 476-487, ISSN: 0022-3565, PMID: 32273303,

YOUSSEF, M., J. DE SANCTIS, C. KANAGARATHAM, S. TAO, E. AHMED, D. RADZIOCH

Efficacy of Optimized Treatment Protocol Using LAU-7b Formulation against Ovalbumin (OVA) and House Dust Mite (HDM) -Induced Allergic Asthma in Atopic Hyperresponsive A/J Mice. Pharmaceutical Research. 2020, 37(2), 31, ISSN: 0724-8741, PMID: 31915990,

GARIC, D., J. DE SANCTIS, D. DUMUT, J. SHAH, J. PENA, M. YOUSSEF, B. PETROF, F. KOPŘIVA, J. HANRAHAN, M. HAJDÚCH, D. RADZIOCH

Fenretinide favorably affects mucins (MUC5AC/MUC5B) and fatty acid imbalance in a manner mimicking CFTR-induced correction. Biochimica et biophysica acta. Molecular and cell biology of lipids. 2019, 1865(2), 158538, ISSN: 1388-1981, PMID: 31678518,

Journals

Radzioch Danuta